SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)

Austria flag Austria · Delayed Price · Currency is EUR
15.74
+0.24 (1.55%)
At close: Jan 13, 2026
-38.27%
Market Cap2.31B
Revenue (ttm)986.21M
Net Income (ttm)146.45M
Shares Outn/a
EPS (ttm)0.97
PE Ratio15.78
Forward PE15.95
Dividend0.18 (1.15%)
Ex-Dividend DateFeb 4, 2026
Volumen/a
Average Volumen/a
Open15.66
Previous Close15.50
Day's Range15.54 - 15.74
52-Week Range14.62 - 30.10
Betan/a
RSI47.13
Earnings DateFeb 11, 2026

About VIE:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Industry Glass Containers
Founded 1884
Employees 4,811
Stock Exchange Vienna Stock Exchange
Ticker Symbol 1SXP
Full Company Profile

Financial Performance

In 2025, VIE:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements

News

There is no news available yet.